Genetic testing to guide statin choice for veterans
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at using a genetic test to help doctors choose the best statin medicine for veterans who need to lower their cholesterol but haven't taken a statin in the last 6 months. If you have diabetes, heart disease, or have had a stroke, this trial may help find a statin that works well for you with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a U.S. military veteran.
- You are between 40 and 75 years old.
- You have diabetes, coronary artery disease, or a history of stroke or blocked leg arteries.
- You have a primary care appointment at the VA within the next 4 months.
- You have not taken any statin medication (from any doctor) in the last 6 months.
- You have at least one current VA prescription and have seen a VA primary care provider in the past 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called colesevelam, which is normally used to lower cholesterol, can help reduce the levels of PFAS (forever chemicals) in your blood. PFAS are harmful chemicals that stick around in the body, and this trial aims to see if the drug can help remove them, potentially lowering your risk of health problems.
This study looks at how your genes affect a new medicine that helps lower cholesterol when statins alone aren't enough. If you join, you'll add this medicine to your current statin to see if it helps you reach your cholesterol goals.
This trial tests a one-time gene therapy to lower extremely high cholesterol in people with a rare inherited condition. It may help reduce heart attack risk in those who haven't responded to standard treatments.
This trial tests an experimental treatment that uses tiny particles to deliver a genetic message to help lower very high cholesterol caused by a rare inherited condition. It may offer a new option for people who have not responded to standard treatments.
This trial tests a new gene therapy called YOLT-101 for people with familial hypercholesterolemia, a genetic condition that causes very high cholesterol. The treatment aims to lower cholesterol levels and reduce heart risks.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
Hear when a new Hypercholesterolemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.